Fund shareholders of Axsome Therapeutics Inc
ISIN US05464T1043 · United States · LEI 549300EXGR0XLRJEIB95
- Fund shareholders
- 349
- Of which ETFs
- 67 282 other funds
- Value held
- 2.9B $ 665.9K € · 21.6M SEK
- Share of capital
- 31.3 % of 52.4M shares on Aug 3, 2026
349 funds hold this company. This table lists the 348 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 533 | 90.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Longboard Fund NORTHERN LIGHTS FUND TRUST II | 528 | 86.5K $ | 0.08 % | 0.00 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Growth Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 524 | 85.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 468 | 97.2K $ | 0.17 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Health Care Fund Rydex Series Funds | 434 | 73.4K $ | 0.38 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA T. Rowe Price Allocation Moderately Aggressive Portfolio SUNAMERICA SERIES TRUST | 431 | 89.5K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 392 | 66.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Lazard Retirement US Small Cap Equity Select Portfolio LAZARD RETIREMENT SERIES INC | 380 | 64.2K $ | 0.73 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 339 | 57.3K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 335 | 54.9K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| AAM Sawgrass U.S. Small Cap Quality Growth ETF ETF Series Solutions | 301 | 62.5K $ | 0.89 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 288 | 59.8K $ | 0.39 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 278 | 57.8K $ | 1.71 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 244 | 41.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Virtus Silvant Small/Mid Growth ETF Virtus ETF Trust II | 235 | 48.8K $ | 1.54 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 233 | 48.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 227 | 38.4K $ | 0.31 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIMT Multi-Asset Inflation Managed Fund SEI INSTITUTIONAL MANAGED TRUST | 209 | 35.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 204 | 34.5K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 169 | 28.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small Company Growth Portfolio Wilshire Mutual Funds Inc | 165 | 27.9K $ | 0.13 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Global Atlantic BlackRock Disciplined Value Portfolio Forethought Variable Insurance Trust | 159 | 26.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Small-Cap Equity V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 153 | 25.9K $ | 0.12 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 139 | 23.5K $ | 0.15 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Motley Fool Innovative Growth Factor ETF RBB Fund, Inc. | 111 | 18.2K $ | 0.30 % | 0.00 % | as of Feb 28, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 105 | 17.7K $ | 0.15 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 94 | 15.9K $ | 0.12 % | 0.00 % | as of Mar 31, 2026 ↗ |
| RiverNorth Patriot ETF Elevation Series Trust | 94 | 15.9K $ | 0.42 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 88 | 14.9K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JPMorgan Fundamental Data Science Small Core ETF J.P. Morgan Exchange-Traded Fund Trust | 87 | 14.7K $ | 0.20 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Sustainable U.S. Market Fund Fidelity Summer Street Trust | 85 | 17.7K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 80 | 13.1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 76 | 15.8K $ | 0.20 % | 0.00 % | as of Apr 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 63 | 13.1K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 56 | 9.5K $ | 0.16 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Conservative Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 51 | 8.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 42 | 6.9K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 28 | 4.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Motley Fool Momentum Factor ETF RBB Fund, Inc. | 28 | 4.6K $ | 0.10 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Kennedy Capital Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST II | 24 | 4.1K $ | 0.82 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Moderate Allocation Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 23 | 3.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 18 | 3K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 13 | 2.1K $ | 0.19 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 11 | 1.9K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 5 | 819.5 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 466.3K € | 0.56 % | as of Dec 31, 2025 ↗ | ||
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 183.3K € | 4.99 % | as of Dec 31, 2025 ↗ | ||
| DIRECTOR GROWTH, FI INVERSIS GESTIÓN, S.A., SGIIC | 16.3K € | 0.49 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 4.99 % | as of Dec 31, 2025 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 4.59 % | as of Apr 30, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.89 % | as of Mar 31, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 2.77 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 2.64 % | as of Apr 30, 2026 ↗ |
| Royce Smaller-Companies Growth Fund ROYCE FUND | 2.64 % | as of Mar 31, 2026 ↗ |
| Eventide Gilead Fund MUTUAL FUND SERIES TRUST | 2.24 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 2.24 % | as of Apr 30, 2026 ↗ |
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 2.15 % | as of Feb 28, 2026 ↗ |
| DANA EPIPHANY SMALL CAP EQUITY FUND Valued Advisers Trust | 2.09 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 344 | +22 | 16,355,934 | +7.2 % |
| 2026Q1 | 322 | +20 | 15,252,151 | +3.4 % |
| 2025Q4 | 302 | +22 | 14,753,211 | +10.9 % |
| 2025Q3 | 280 | +6 | 13,298,689 | +4.4 % |
| 2025Q2 | 274 | +45 | 12,740,413 | +1.1 % |
| 2025Q1 | 229 | +9 | 12,597,294 | +3.3 % |
| 2024Q4 | 220 | +12 | 12,191,616 | +6.5 % |
| 2024Q3 | 208 | -6 | 11,451,674 | +10.6 % |
| 2024Q2 | 214 | +23 | 10,355,823 | +14.7 % |
| 2024Q1 | 191 | -7 | 9,029,568 | +0.7 % |
| 2023Q4 | 198 | 8,966,973 |
Institutional managers
401 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 3,912,844 | 661.3M $ | as of Mar 31, 2026 |
| FMR LLC | 1,566,995 | 264.9M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,317,059 | 222.6K $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,297,678 | 219.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,162,981 | 196.6M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,145,306 | 193.6M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 1,100,000 | 185.9M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 986,809 | 166.8M $ | as of Mar 31, 2026 |
| Assenagon Asset Management S.A. | 865,958 | 146.4M $ | as of Mar 31, 2026 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 812,809 | 137.4M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 737,578 | 124.7M $ | as of Mar 31, 2026 |
| ALETHEA CAPITAL MANAGEMENT, LLC | 649,114 | 109.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 603,465 | 102M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 598,091 | 101.1M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 577,479 | 97.6M $ | as of Mar 31, 2026 |
| UBS Group AG | 547,195 | 92.5M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 519,558 | 87.8M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 476,701 | 80.6M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 438,490 | 74.1M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 424,750 | 71.8M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 421,447 | 71.2M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 415,983 | 70.3M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 401,459 | 67.9M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 395,118 | 66.8M $ | as of Mar 31, 2026 |
| Hood River Capital Management LLC | 371,503 | 62.8M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Axsome Therapeutics Inc". https://titelia.com/en/stocks/axsome-therapeutics-inc-US05464T1043